Vai trò của Các Thụ thể Beta-adrenergic và Đường tín hiệu Sirtuin trong Tim trong Quá trình Lão hóa, Suy Tim, và Thích nghi với Căng thẳng

Adiga IK, Nair RR (2008) Multiple signaling pathways coordinately mediate reactive oxygen species dependent cardiomyocyte hypertrophy. Cell Biochem Funct 26(3):346–351 Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J (2004) Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res 95(10):971–980 Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF, Sadoshima J (2007) Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100(10):1512–1521 Aranguiz-Urroz P, Canales J, Copaja M, Troncoso R, Vicencio JM, Carrillo C, Lara H, Lavandero S, Diaz-Araya G (2011) Beta(2)-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation. Biochem Biophys Acta 1812(1):23–31 Axelrod J, Reisine TD (1984) Stress hormones: their interaction and regulation. Science 224(4648):452–459 Baker AJ (2014) Adrenergic signaling in heart failure: a balance of toxic and protective effects. Pflugers Arch 466:1139–1150 Bassani RA, Bassani JW (1993) Effects of escapable and inescapable foot-shock on rat atrial beta-adrenoceptors. Pharmacol Biochem Behav 44(4):869–875 Benes J, Novakova M, Rotkova J, Farrar V, Kvetnansky R, Riljak V, Myslivecek J (2012) Beta3 adrenoceptors substitute the role of M (2) muscarinic receptor in coping with cold stress in the heart: evidence from M(2)KO mice. Cell Mol Neurobiol 32(5):859–869 Berndt C, Lillig CH, Holmgren A (2007) Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am J Physiol Heart Circ Physiol 292(3):H1227–H1236 Bing RJ, Siegel A, Ungar I et al (1954) Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism. Am J Med 16(4):504–515 Blander G, Guarente L (2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73:417–435 Bohm M, Lohse MJ (1994) Quantification of beta-adrenoceptors and beta-adrenoceptor kinase on protein and mRNA levels in heart failure. Eur Heart J 15(Suppl D):30–34 Bos JL (2006) Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci 31:680–686 Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billing-ham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 307(4):205–211 Bristow MR, Hershberger RE, Port JD, Minobe W, Rasmussen R (1989) Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol 35(3):295–303 Bristow MR, Minobe WA, Raynolds MV, Port JD, Rasmussen R, Ray PE, Feldman AM (1993) Reduced beta 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest 92(6):2737–2745 Brodde OE (1991) Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43(2):203–242 Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303(5666):2011–2015 Cai J, Yi FF, Bian ZY et al (2009) Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway. J Cell Mol Med 13(5):909–925 Cannavo A, Liccardo D, Lymperopoulos A, Santangelo M, Femminella G, Leosco D, Cittadini A, Ferrara N, Paolocci N, Koch WJ, Rengo G (2017) GRK2 regulates α2-adrenergic receptor-dependent catecholamines release in human adrenal chromaffin cells. JACC 69(11):1513–1519 Cerbai E, Guerra L, Varani K, Barbieri M, Borea PA, Mugelli A (1995) Beta-adrenoceptor subtypes in young and old rat ventricular myocytes: a combined patch-clamp and binding study. Br J Pharmacol 116(2):1835–1842 Chao LC, Tontonoz P (2012) SIRT1 regulation—it ain’t all NAD. Mol Cell 45:9–11 Chen T, Liu J, Li N et al (2015) Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD. PLoS ONE 10(3):e0118909 Corbi G, Conti V, Scapagnini G, Filippelli A, Ferrara N (2012) Role of sirtuins, calorie restriction and physical activity in aging. Front Biosci (Elite Ed) 4:768–778 Corbi G, Conti V, Russomanno G, Longobardi G, Furgi G, Filippelli A, Ferrara N (2013) Adrenergic signaling and oxidative stress: a role for sirtuins? Front Physiol 4:1–14 Daaka Y, Luttrell LM, Lefkowitz RJ (1997) Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390(6655):88–91 Daitoku H, Hatta M, Matsuzaki H et al (2004) Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. PNAS 101(27):10042–10047 Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK, Kapiloff MS, Scott JD (2005) The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 437(7058):574–578 Du J, Zhou Y, Su X, Yu JJ, Khan S, Jiang H, Kim J, Woo J, Kim JH, Choi BH, He B, Chen W, Zhang S, Cerione RA, Auwerx J, Hao Q, Lin H (2011) Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334(6057):806–809 Faulx MD, Ernsberger P, Vatner D, Hoffman RD, Lewis W, Strachan R, Hoit BD (2005) Strain-dependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice. Am J Physiol Heart Circ Physiol 289(1):H30–36 Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Van Dop C (1988) Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest 82(1):189–197 Ferrara N, O’Gara P, Wynne DG, Brown LA, del Monte F, Poole-Wilson PA, Harding SE (1995) Decreased contractile responses to isoproterenol in isolated cardiac myocytes from aging guinea-pigs. J Mol Cel Cardiol 27(5):1141–1150 Ferrara N, Bohm M, Zolk O, O’Gara P, Harding SE (1997) The role of Gi-proteins and beta-adrenoceptors in the age-related decline of contraction in guinea-pig ventricular myocytes. J Mol Cel Cardiol 29(2):439–448 Ferrara N, Komici K, Corbi G, Pagano G, Furgi G, Rengo C, Femminella GD, Leosco D, Bonaduce D (2014) Beta-adrenergic receptor responsiveness in aging heart and clinical implications. Front Physiol 4:1–10 Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J et al (2011) SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell 19:416–428 Frescas D, Valenti L, Accili D (2005) Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem 280(21):20589–20595 Frye RA (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 273(2):793–798 Gerhart-Hines Z, Dominy Jr JE, Blattler SM, Jedrychowski MP, Banks AS, Lim J, Chim H, Gygi SP, Pulgserver P (2011) The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+). Mol Cell 44:851–863 Gilsbach R, Hein L (2012) Are the pharmacology and physiology of α 2- adrenoceptors determined by α2- heteroreceptors and auto receptors respectively? Br J Pharm 165:90–102 Gudbjarnason S, Benediktsdottir VE (1996) Regulation of beta-adrenoceptor properties and the lipid milieu in heart muscle membranes during stress. Mol Cel Biochem 163(1):137–143 Guo J, Gertsberg Z, Ozgen N (2009) p66Shc links α1-adrenergic receptors to a reactive oxygen species-dependent AKT-FOXO3A phosphorylation pathway in cardiomyocytes. Circ Res 104(5):660–669 Hafner AV, Dai J, Gomes AP et al (2010) Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2(12):914–923 Hariharan N, Maejima Y, Nakae J, Paik J, Depinho RA, Sadoshima J (2010) Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ Res 107(12):1470–1482 Houtkooper RH, Pirinen E, Auwerx J (2012) Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13(4):225–238 Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, Shao D, Takagi H, Oka S, Sadoshima J (2010) Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 122(21):2170–2182 Huang H, Tindall DJ (2007) Dynamic FoxO transcription factors. J Cell Sci 120(Pt 15):2479–2487 Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rah PS, Silver MA, Stevenson LW, Yancy CW (2009) Focused update incorporated into the ACC/AHA 205 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Socitt for Heart and Lung Transplantation. J Am Coll Cardiol 53:e1–e90 Imai S, Armstrong CM, Kaeberlein M, Guarente L (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403(6771):795–800 Kaabachi O, Ouezini R, Koubaa W, Ghrab B, Zargouni A, Ben Abdelaziz A (2009) Tramadol as an adjuvant to lidocaine for axillary brachial plexus block. Anesth Analg 108(1):367–370 Koentges C, Pfeil K, Schnick T et al (2015) SIRT3 deficiency impairs mitochondrial and contractile function in the heart. Basic Res Cardiol 110(4):36 Koentges C, Bode C, Bugger H (2016) SIRT3 in cardiac physiology and disease. Front Cardiovasc Med 3(38):1–8 Laukova M, Vargovic P, Vlcek M, Lejavova K, Hudecova S, Krizanova O, Kvetnansky R (2013) Catecholamine production is differently regulated in splenic T- and B-cells following stress exposure. Immunobiology 218(5):780–789 Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, Tsokos M, Alt FW, Finkel T (2008) A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Nat Acad Sci USA 105(9):3374–3379 Leineweber K, Klapproth S, Beilfuss A, Silber RE, Heusch G, Philipp T, Brodde OE (2003) Unchanged G-protein-coupled receptor kinase activity in the aging human heart. J Am Coll Cardiol 42(8):1487–1492 Levine S (2005) Developmental determinants of sensitivity and resistance to stress. Psychoneuroendocrinology 30(10):939–946 Li HL, Huang Y, Zhang CN et al (2006) Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic Biol Med 40(10):1756–1775 Liggett SB, Cresci S, Kelly RJ, Syed FM, Matkovich SJ, Hahn HS, Diwan A, Martini JS, Sparks L, Parekh RR, Spertus JA, Koch WJ, Kardia SL, Dorn GW 2nd (2008) A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med 14(5):510–517 Lokuta AJ, Maertz NA, Meethal SV, Potter KT, Kamp TJ, Valdivia HH, Haworth RA (2005) Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure. Circulation 111(8):988–995 Lymperopoulos A, Rengo G, Funakishi H, Eckhart AD, Koch WJ (2007) Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat Med 13:315–323 Lymperopoulos A, Rengo G, Gao E, Ebert SN, Dorn GW, Koch WJ (2010) Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction. J Biol Chem 285(21):16378–16386 Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, Goldberg AL, Schiaffino S, Sandri M (2007) FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6(6):458–471 Mann DL, Bristow MR (2005) Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111:2837–2849 McEwen BS (2000) The neurobiology of stress: from serendipity to clinical relevance. Brain Res 886(1–2):172–189 Molenaar P, Christ T, Hussain RI, Engel A, Berk E, Gillette KT, Chen L, Galindo-Tovar A, Krobert KA, Ravens U, Levy FO, Kaumann AJ (2013) PDE3, but not PDE4, reduces beta (1) - and beta(2)-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients. Brit J Pharmacol 169(3):528–538 Moura AL, Hyslop S, Grassi-Kassisse DM, Spadari RC (2017) Functional beta 2 adrenoceptors in rat left atria: effect of foot-shock stress. Can J Physiol Pharmacol (in press) Myagmar B-E, Flynn JM, Cowley FM, Swigart PM, Montgomery MD, Thai K, Nair D, Gupta R, Deng DX, Hosoda C, Melov S, Baker AJ, Simpson PC (2017) Adrenergic receptors in individual ventricular myocytes: the beta-1 and alpha-1B are in all cells, the alpha-1A is in a subpopulation, and the beta-2 and beta-3 are almost absent. Circ Res 120:1103–1115 Myslivecek J, Ricny J, Palkovits M, Kvetnansky R (2004) The effects of short-term immobilization stress on muscarinic receptors, beta-adrenoceptors, and adenylyl cyclase in different heart regions. Annals NY Acad Sci 1018:315–322 Myslivecek J, Tillinger A, Novakova M, Kvetnansky R (2008) Regulation of adrenoceptor and muscarinic receptor gene expression after single and repeated stress. Annals NY Acad Sci 1148:367–376 Nakou ES, Parthenakis FI, Kallergis EM, Marketou ME, Nakos KS, Vardas PE (2016) Healthy aging and myocardium: a complicated process with various effects in cardiac structure and physiology. Int J Cardiol 209:167–175 Nikolaev VO, Moshkov A, Lyon AR, Miragoli M, Novak P, Paur H et al (2010) β2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 327:1653–1657 O’Hayre M, Eichel K, Avino S, Zhao X, Steffen DJ, Feng X, Kawakami K, Aoki J, Messer K, Sunahara R, Inoue A, von Zastrow M, Gutkind JS (2017) Genetic evidence that β-arrestins are dispensable for the initiation of β2-adrenergic receptor signaling o ERK. Sci Signal 10: eaal3395 Penna LB, Bassani RA (2010) Increased spontaneous activity and reduced inotropic response to catecholamines in ventricular myocytes from footshock-stressed rats. Stress 13(1):73–82 Pereira L, Cheng H, Lao DH, Na L, van Oort RJ, Brown JH, Wehrens XH, Chen J, Bers DM (2013) Epac2 mediates cardiac beta1-adrenergic-dependent sarcoplasmic reticulum Ca2+ leak and arrhythmia. Circulation 127:913–922 Pillai JB, Isbatan A, Imai S, Gupta MP (2005) Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity. J Biol Chem 280(52):43121–43130 Rockman HA, Chien KR, Choi DJ, Iaccarino G, Hunter JJ, Ross J Jr, Lefkowitz RJ, Koch WJ (1998) Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Nat Acad Sci USA 95(12):7000–7005 Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434(7029):113–118 Santos IN, Spadari-Bratfisch RC (2006) Stress and cardiac beta adrenoceptors. Stress 9(2):69–84 Sato M, Gong H, Terracciano CM, Ranu H, Harding SE (2004) Loss of beta-adrenoceptor response in myocytes overexpressing the Na+/Ca(2+)-exchanger. J Mol Cell Cardiol 36(1):43–48 Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS (2002) Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34:379–388 Sciarretta S, Hariharan N, Monden Y, Zablocki D, Sadoshima J (2011) Is autophagy in response to ischemia and reperfusion protective or detrimental for the heart? Pediatr Cardiol 32(3):275–281 Seddon M, Looi YH, Shah AM (2007) Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93:903–907 Selye HA (1936) A syndrome produced by diverse noxious agents. J Neurons Clin Neurosci 10(2):230–231 Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, Izumo S (2000) The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19(11):2537–2548 Sormekawa S, Fukuhara S, Nakaoka Y, Fujita H, Saito Y, Mochizuki N (2005) Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ Res 97:655–662 Spadari-Bratfisch RC, dos Santos IN (2008) Adrenoceptors and adaptive mechanisms in the heart during stress. Ann NY Acad Sci 1148:377–383 Stanley WC, Chandler MP (2002) Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev 7(2):115–130 Stanley BA, Sivakumaran V, Shi S, McDonald I, Lloyd D, Watson WH, Aon MA, Paolocci N (2011) Thioredoxin reductase-2 is essential for keeping low levels of H2O2 emission from isolated heart mitochondria. J Biol Chem 286(38):33669–33677 Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP (2009) Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 119(9):2758–2771 Sundaresan NR, Vasudevan P, Zhong L, Kim G, Samant S, Parekh V, Pillai VB, Ravindra PV, Gupta M, Jeevanandam V, Cunningham JM, Deng CX, Lombard DB, Mostoslavsky R, Gupta MP (2012) The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat Med 18(11):1643–1650 Tan WQ, Wang K, Lv DY et al (2008) Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase. J Biol Chem 283(44):29730–29739 Tanno M, Nakamoto J, Miura T, Shimamoto K, Horio Y (2007) Nucleocytoplasmic shuttling of the NAD + dependent histone deacetylase SIRT1. J Biol Chem 282:6823–6832 Tanno M, Kuno A, Yano T, Miura T, Hisahara S, Ishikawa S et al (2010) Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285:8375–8382 Tanno M, Kuno A, Horio Y, Miura T (2012) Emerging beneficial roles of sirtuins in heart failure. Basic Res Cardiol 107(4):273–287 Tillinger A, Myslivecek J, Novakova M, Krizanova O, Kvetnansky R (2008) Gene expression of adrenoceptors in the hearts of cold-acclimated rats exposed to a novel stressor. Ann NY Acad Sci 1148:393–399 Tillinger A, Novakova M, Krizanova O, Kvetnansky R, Myslivecek J (2014) Heart ventricles specific stress-induced changes in beta-adrenoceptors and muscarinic receptors. Gen Physiol Biophys 33(3):357–364 Tong C, Morrison A, Mattison S, Qian S, Bryniarski M, Rankin B, Wang J, Thomas DP, Li J (2013) Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress. FASEB J 27(11):4332–4342 Tseng AH, Shieh SS, Wang DL (2013) SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage. Free Radic Biol Med 63:222–234 Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ (1993) Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 87(2):454–463 Vakhrusheva O, Smolka C, Gajawada P, Kostin S, Boettger T, Kubin T, Braun T, Bober E (2008) Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res 102(6):703–710 van der Horst A, Tertoolen LG, de Vries-Smits LM, Frye RA, Medema RH, Burgering BM (2004) FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J Biol Chem 279(28):28873–28879 Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, Reinberg D (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 16(1):93–105 Vaquero A, Sternglanz R, Reinberg D (2007) NAD + -dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene 26(37):5505–5520 Varma SD (1991) Devamanoharan PS hydrogen peroxide in human blood. Free Radic Res Commun 14:125–131 Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107(2):149–159 Villalba JM, Alcain FJ (2012) Sirtuin activators and inhibitors. BioFactors 38(5):349–359 Wanschel AC, Caceres VM, Moretti AI, Bruni-Cardoso A, de Carvalho HF, de Souza HP, Laurindo FR, Spadari RC, Krieger MH (2014) Cardioprotective mechanism of S-nitroso-N-acetylcysteine via S-nitrosated betadrenoceptor-2 in the LDLr-/- mice. Nitric Oxide 36:58–66 Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, Luttrell LM, Lefkowitz RJ (2003) Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci USA 100:10782–10787 White M, Roden R, Minobe W, Khan MF, Larrabee P, Wollmering M, Port JD, Anderson F, Campbell D, Feldman AM (1994) Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 90 (3):1225–1238 Woo AY, Xiao RP (2012) Beta-Adrenergic receptor subtype signaling in heart: from bench to bedside. Acta Pharmacol Sin 33(3):335–341 Woo AY, Song Y, Xiao RP, Zhu W (2015) Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery. Br J Pharmacol 172:5444–5456 Xiao RP, Balke CW (2004) Na +/Ca2 + exchange linking beta2-adrenergic G(i) signaling to heart failure: associated defect of adrenergic contractile support. J Mol Cel Cardiol 36(1):7–11 Xiao RP, Ji X, Lakatta EG (1995) Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol 47(2):322–329 Xiao RP, Tomhave ED, Wang DJ, Ji X, Boluyt MO, Cheng H, Lakatta EG, Koch WJ (1998) Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest 101(6):1273–1282 Xu Q, Dalic A, Fang L, Kiriazis H, Ritchie RH, Sim K, Gao X-M, Drummond G, Sarwar M, Zhang Y-Y, Dart AM, Du X-J (2011) Myocardial oxidative stress contributes to transgenic β2-adrenoceptor activation-induced cardiomyopathy and heart failure. Br J Pharmacol 162:1012–1028 Yue Z, Ma Y, You J et al (2016) NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy. Exp Cell Res 347(2):261–273 Zeng H, Vaka VR, He X et al (2015) High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss. J Cell Mol Med 19(8):1847–1856 Zhang XP, Vatner SF, Shen YT, Rossi F, Tian Y, Peppas A, Resuello R, Natividad FF, Vatner D (2007) Increased apoptosis and myocyte enlargement with decreased cardiac mass, distinctive features of the aging male, but not female, monkey heart. J Mol Cell Cardiol 43(4):487–491 Zhang L, Zhang Z, Guo H et al (2008) Na+/K+-ATPase-mediated signal transduction and Na+/K+-ATPase regulation. Fundam Clin Pharmacol 22(6):615–621 Zhang L, D’Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD, Guimaraes A, Marinelli B, Wikstrom JD, Nir T, Clish CB, Vaitheesvaran B, Iliopoulos O, Kurland I, Dor Y, Weissleder R, Shirihai OS, Ellisen LW, Espinosa JM, Mostoslavsky R (2010) The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 140(2):280–293 Zhang W, Yano N, Deng M, Mao Q, Shaw SK, Tseng YT (2011) Beta-adrenergic receptor-PI3 K signaling crosstalk in mouse heart elucidation of immediate downstream signaling cascades. PLoS ONE 6(10):e26581 Zhu WZ, Zheng M, Koch WJ, Lefkowitz RJ, Kobilka BK, Xiao RP (2001) Dual modulation of cell survival and cell death by β2-adrenergic signaling in adult mouse cardiac myocytes. Proc Nat Acad Sci USA 98(4):1607–1612 Zhu WZ, Wang SQ, Chakir K, Yang D, Zhang T, Brown JH, Devic E, Kobilka BK, Cheng H, Xiao RP (2003) Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest 111(5):617–625 Zhu W, Zeng X, Zheng M, Xiao RP (2005) The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly. Circ Res 97(6):507–509 Zhu W, Petrashevskaya N, Ren S, Zhao A, Chakir K, Gao E, Chuprun JK, Wang Y, Talan M, Dorn GW 2nd, Lakatta EG, Feldman Koch WJ, Xiao RP AM (2012) Gi-biased beta2AR signaling links GRK2 upregulation to heart failure. Circ Res 110(2):265–274 Zou XJ, Yang L, Yao SL (2008) Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro. Exp Biol Med (Maywood) 233(2):200–208